Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Vitamin B12 is not a substitute for folic acid and since it might improve folic acid deficient megaloblastic anemia, indiscriminate use of vitamin B12 could mask the true diagnosis
The committee will evaluate: Available safety and pharmacological data on DSIP Clinical evidence supporting its use for sleep regulation and related conditions Quality control considerations for compounding DSIP formulations Public comments from patients, sleep specialists, and the compounding pharmacy community Possible outcomes range from a positive recommendation for 503A compounding to a request for additional data
B12 deficiency produces a recognizable cluster of symptoms: fatigue, weakness, neurological changes including tingling or numbness in the extremities, cognitive fog, and in more severe cases, megaloblastic anemia
Subcutaneous peptide injections occasionally cause localized redness or mild swelling, but serious reactions are rare
TB-500's immune-modulating effects may reduce systemic inflammation driving both joint and skin symptoms, but direct evidence is limited
Dose ranges are often species- and model-dependent, with rodent studies using body-weight-normalized doses (mcg/kg or mg/kg) that may be substantially different from the fixed doses used in primate or pharmacokinetic models
